1. Home
  2. GLU vs MDXH Comparison

GLU vs MDXH Comparison

Compare GLU & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

HOLD

Current Price

$18.53

Market Cap

110.5M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.32

Market Cap

167.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
MDXH
Founded
2004
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
110.5M
167.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GLU
MDXH
Price
$18.53
$3.32
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
12.4K
182.7K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
8.60%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
N/A
$103,069,000.00
Revenue This Year
N/A
$23.34
Revenue Next Year
N/A
$22.98
P/E Ratio
$22.50
N/A
Revenue Growth
N/A
21.68
52 Week Low
$11.61
$1.35
52 Week High
$15.40
$5.33

Technical Indicators

Market Signals
Indicator
GLU
MDXH
Relative Strength Index (RSI) 52.51 34.99
Support Level $18.32 $3.31
Resistance Level $18.61 $3.74
Average True Range (ATR) 0.20 0.18
MACD 0.01 0.01
Stochastic Oscillator 53.07 8.65

Price Performance

Historical Comparison
GLU
MDXH

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: